KPV peptide is a synthetic tripeptide composed of the amino acids lysine, proline, and valine. It has gained attention in scientific research for its anti-inflammatory properties and potential therapeutic applications in conditions such as chronic inflammation, autoimmune disorders, and certain types of cancer. The product you are interested in is packaged as a 10 mg KPV vial box containing ten individual vials, which together provide a total of 100 mg of the peptide.
Product Overview The package includes ten pre-filled vials, each labeled with a dosage of 10 mg. The vial size and concentration allow for precise dosing, making it suitable for laboratory studies where reproducible results are essential. The total quantity of 100 mg in the box offers ample material for multiple experiments or extended studies without the need to repurchase frequently.
Key Features
Concentration: Each vial contains 10 mg of KPV peptide.
Packaging: Ten individual vials per box, ensuring each dose is isolated and free from cross-contamination.
Total Quantity: 100 mg across all ten vials, sufficient for extended research projects or multiple dosing regimens.
Storage Conditions: The product is typically supplied as a lyophilized powder that should be reconstituted with sterile water or buffer before use. It is best stored at −20°C to maintain stability.
Applications KPV peptide has been studied in various preclinical models, including:
Anti-inflammatory effects in murine models of arthritis and colitis.
Modulation of cytokine production in immune cells.
Potential anti-tumor activity when combined with other therapeutic agents.
When preparing the peptide for experiments, it is important to follow standard aseptic techniques. Reconstitution should be performed using a sterile diluent that matches the intended downstream application, whether cell culture or animal injection. Once reconstituted, aliquots can be frozen in small volumes to avoid repeated freeze–thaw cycles which may degrade the peptide.
Quality and Purity The KPV peptide sold in this format is typically synthesized by solid-phase synthesis with subsequent purification steps such as high-performance liquid chromatography. The purity of the product should be verified by mass spectrometry or analytical HPLC before use, especially if it will serve as a standard in quantitative assays. Certificates of analysis are usually provided to confirm batch consistency and purity levels above 95%.
Regulatory Considerations Because KPV is considered a research chemical rather than an approved pharmaceutical, its usage is restricted to laboratory settings. Researchers must ensure compliance with institutional guidelines for handling peptides and any regulatory requirements concerning the import or sale of synthetic compounds.
Safety and Handling Although KPV itself does not pose significant acute toxicity, it should be handled with gloves and eye protection as a precautionary measure. The reconstituted solution may need to be filtered through a 0.22 micron filter to remove particulates before use in cell culture or animal studies.
Conclusion The 10 mg – 10 Vial Box of KPV peptide provides researchers with a convenient, high-quality source of this anti-inflammatory tripeptide. Its clear labeling and sufficient total quantity make it an attractive option for laboratories conducting dose-response studies or long-term investigations into the therapeutic potential of KPV in inflammatory and oncologic disease models.
